Insulin inhalation is a rapid-acting form of human insulin that is inhaled through the
mouth. It works by lowering levels of glucose (sugar) in the blood.
Insulin inhalation is used to treat type 1 (insulin dependent) or type 2 (non-insulin
dependent) diabetes in adults.
Insulin inhalation (Exubera) was withdrawn from the U.S. market in 2007 due to lack
of consumer demand for the product. No drug safety concerns were cited in this withdrawal.
Insulin inhalation may also be used for purposes other than those listed here.